Banco De Sabadell, S.A Abb Vie Inc. Transaction History

Banco De Sabadell, S.A

$133 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $84,486 - $95,151	-614 Reduced 40.45%	904 $140,000
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $69,733 - $80,727	522 Added 52.41%	1,518 $229,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $20,936 - $26,054	158 Added 18.85%	996 $133,000
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $51,914 - $59,787	359 Added 74.95%	838 $133,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $13,001 - $15,591	94 Added 24.42%	479 $78,000
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $52,983 - $67,359	385 New	385 $59,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $3.08 Million - $3.39 Million	-30,090 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $2.17 Million - $2.93 Million	26,962 Added 861.96%	30,090 $3.18 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $4.46 Million - $5.23 Million	-51,877 Reduced 94.31%	3,128 $273,000
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $1.13 Million - $1.51 Million	-15,367 Reduced 21.84%	55,005 $5.35 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $2.54 Million - $3.86 Million	39,440 Added 127.51%	70,372 $5.33 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.86 Million - $2.33 Million	25,852 Added 508.9%	30,932 $2.74 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $1.76 Million - $2.17 Million	-22,648 Reduced 81.68%	5,080 $466,000
Q3 2018 Nov 16, 2018	SELL	$88.91 - $98.84 $8,624 - $9,587	-97 Reduced 0.35%	27,728 $2.62 Million
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $2.11 Million - $2.5 Million	23,545 Added 550.12%	27,825 $2.58 Million
Q1 2018 May 16, 2018	SELL	$92.01 - $123.21 $1.54 Million - $2.06 Million	-16,744 Reduced 79.64%	4,280 $402,000
Q4 2017 Feb 16, 2018	BUY	$89.56 - $98.21 $1.88 Million - $2.06 Million	21,024	21,024 $2.03 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.

Account